These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3081571)

  • 1. Ovulation inhibition by administration of weekly gonadotropin-releasing hormone antagonist.
    Kenigsberg D; Hodgen GD
    J Clin Endocrinol Metab; 1986 Apr; 62(4):734-8. PubMed ID: 3081571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen.
    Werlin LB; Hodgen GD
    J Clin Endocrinol Metab; 1983 Apr; 56(4):844-8. PubMed ID: 6403565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist?
    Collins RL; Hodgen GD
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1270-6. PubMed ID: 3097053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular stimulation versus ovulation induction in juvenile primates: importance of gonadotropin-releasing hormone dose.
    Sopelak VM; Collins RL; Hodgen GD
    J Clin Endocrinol Metab; 1986 Mar; 62(3):557-62. PubMed ID: 3080466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW; Gordon K; Billiar RB; Little AB
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
    Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P
    J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiovulatory actions of RU 486: the pituitary is not the primary site of action in vivo.
    Heikinheimo O; Gordon K; Lähteenmäki P; Williams RF; Hodgen GD
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1859-68. PubMed ID: 7775633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible protocol for administration of human follicle-stimulating hormone with gonadotropin-releasing hormone antagonist.
    Byrd S; Itskovitz J; Chillik C; Hodgen GD
    Fertil Steril; 1992 Jan; 57(1):209-14. PubMed ID: 1730319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone antagonists attenuate estrogen/progesterone-induced hyperprolactinemia in monkeys.
    Olive DL; Sabella V; Riehl RM; Schenken RS; Moreno A
    Fertil Steril; 1989 Jun; 51(6):1040-5. PubMed ID: 2656304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle.
    Fluker MR; Marshall LA; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1991 Apr; 72(4):912-9. PubMed ID: 2005218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical hypophysectomy: I. Dose-response using a gonadotropin-releasing hormone antagonist.
    Kenigsberg D; Littman BA; Hodgen GD
    Fertil Steril; 1984 Jul; 42(1):112-5. PubMed ID: 6427024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent GnRH antagonist plus progestin contraception conserving tonic ovarian estrogen secretion and reducing progestin exposure.
    Danforth DR; Williams RF; Hsiu JG; Roh SI; Hahn D; McGuire JL; Hodgen GD
    Contraception; 1990 Jun; 41(6):623-31. PubMed ID: 2113850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
    Zelinski-Wooten MB; Lanzendorf SE; Wolf DP; Chandrasekher YA; Stouffer RL
    J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the timing of controlled internal drug-releasing device insertion on the gonadotropin-releasing hormone-induced luteinizing hormone surge and ovulatory response.
    Perry GA; Perry BL
    J Anim Sci; 2009 Dec; 87(12):3983-90. PubMed ID: 19684266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a specific role of GnRH pulse frequency in the control of the human menstrual cycle.
    Filicori M; Flamigni C; Campaniello E; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A; Valdiserri A
    Am J Physiol; 1989 Dec; 257(6 Pt 1):E930-6. PubMed ID: 2514600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human menopausal gonadotropin stimulation in monkeys: blockade of the luteinizing hormone surge by a highly transient ovarian factor.
    Littman BA; Hodgen GD
    Fertil Steril; 1984 Mar; 41(3):440-7. PubMed ID: 6421627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation.
    Christin-Maitre S; Olivennes F; Dubourdieu S; Chabbert-Buffet N; Charbonnel B; Frydman R; Bouchard P
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):721-6. PubMed ID: 10848876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone blocks the estradiol-induced gonadotropin discharge in the ewe by inhibiting the surge of gonadotropin-releasing hormone.
    Kasa-Vubu JZ; Dahl GE; Evans NP; Thrun LA; Moenter SM; Padmanabhan V; Karsch FJ
    Endocrinology; 1992 Jul; 131(1):208-12. PubMed ID: 1611998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.